What is Alto Neuroscience's tax on share settlement?

Alto Neuroscience (ANRO) reported tax on share settlement of $190K in Q1 2026.

What does tax on share settlement mean?

Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.

Alto Neuroscience ANRO Tax on Share Settlement

Tax on Share Settlement at other companies

Praxis Precision Medicines, Inc.PRAX

$12.92M+981%

MeiraGTx Holdings plcMGTX

$5.96M+116%

MapLight Therapeutics, Inc. MPLT

$7.5M—

Axsome TherapeuticsAXSM

$9.3M+115%

AlkermesALKS

$23.44M-18.6%

Supernus PharmaceuticalsSUPN

$4.56M+36.3%

Other financials

Income statement

See full

Operating income-$27.1M-73.1%

Net income-$26.2M-73.0%

EPS (diluted)-$0.80-42.9%

Balance sheet

See full

Cash & equivalents$264.3M+63.9%

Total debt$20.9M-17.2%

Total equity$243.4M+75.0%

Total assets$276.3M+60.7%

Cash flow

See full

Operating cash flow-$27.1M-63.6%

CapEx$556.0K+2,217%

Free cash flow-$27.6M-66.7%

Valuation

See full

Market cap$874.19M+1,358%

Enterprise value$630.81M-958%

Returns & leverage

See full

Return on equity-38.9%+0.9pp

Debt / equity0.1×-0.1×

Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alto Neuroscience's tax on share settlement?: Alto Neuroscience (ANRO) reported tax on share settlement of $190K in Q1 2026.
What does tax on share settlement mean?: Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.